Sanofi-Aventis Deutschland GmbH,   Germany

Allegra
Antiallergic agent - H1-histamine receptor blocker

Tablets, film-coated, 120 mg and 180 mg.

Amaryl®
hypoglycemic agent for oral use of the sulfonylurea group of the third generation

Tablets 1 mg, 2 mg, 3 mg, 4 mg.


Apidra®
hypoglycemic agent - short-acting insulin analog

Solution for subcutaneous administration, 100 units / ml.

Apidra® SoloStar®
Hypoglycemic agent - short-acting insulin analog

Solution for subcutaneous administration, 100 U / ml.

Arava®
Immunosuppressive remedy

Tablets coated with 10 mg, 20 mg and 100 mg.

Batrafen®
Antifungal agent

Nail polish 8%.

Insulin Glargine
hypoglycemic agent - long-acting insulin analog

Solution for subcutaneous administration, 100 units / ml.

Insuman® Bazal GT
hypoglycemic agent - medium-duration insulin

Suspension for subcutaneous administration, 100 IU / ml.

Insuman Rapid GT
hypoglycemic agent - short-acting insulin
Solution for injection, 100 IU / ml.
Lantus® SoloStar®
hypoglycemic agent - long-acting insulin analog

Solution for subcutaneous administration, 100 units / ml.

Tavanic®
Antimicrobial agent - fluoroquinolone
Tablets, film-coated, 250 mg, 500 mg.
Tavanic®
Antimicrobial agent - fluoroquinolone

Solution for infusions 5 mg / ml.

Tarivid®
antimicrobial agent, fluoroquinolone.

Solution for infusion, 2 mg / ml.


Triapin®
(angiotensin-converting enzyme (ACE) inhibitor + blocker of "slow" calcium channels (BCCC)

Tablets of prolonged action, covered with a film membrane (2.5 mg + 2.5 mg).

Tablets of prolonged action, film-coated (5 mg + 5 mg).

For 10 or 14 tablets in a blister of PVC / aluminum foil.For 2 or 3 blisters together with instructions for use in a cardboard box.

Tritace®
inhibitor of angiotensin-converting enzyme (ACE).

Tablets of 10 mg. For 14 tablets in a blister, made of PVC / aluminum foil. 2 blisters together with instructions for use in a cardboard box.

Tudzheo SoloStar®
hypoglycemic agent - long-acting insulin analog
Solution for subcutaneous administration, 300 units / ml.
Ultracaine® D
local anesthetic

Solution for injection 40 mg / ml.

Ultracaine® D-C
local anesthetic + α- and β-adrenomimetic
Solution for injection 40 mg / ml + 0.005 mg / ml, in ampoules of 2 ml and in cartridges of 1.7 ml.
Ultrakain® D-C Fort
local anesthetic + α- and β-adrenomimetic
Solution for injection 40 mg / ml + 0.010 mg / 1 ml.